TOR signalling and control of cell growth

Current Opinion in Cell Biology

Volumn 9, Issue 6, 1997, Pages 782-787

  Thomas, George ^a   Hall, Michael N ^b  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN; PROTEIN KINASE;

CELL GROWTH; DICTYOSTELIUM DISCOIDEUM; INSECT; MAMMAL; PLANT; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; YEAST;

EID: 0030707562     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(97)80078-6     Document Type: Article

References (49)

1. 1 progression. Cell 1993, 73:585-596.
2. Keith CT, Schreiber SL: PIK-related kinases: DNA repair, recombination, and cell cycle check points. Science 1995, 270:50-51.
3. Abraham RT: Phosphoinositol 3-kinase related kinases. Curr Opin Immunol 1996, 8:412-418.
4. Keegan KS, Holtzman DA, Plug AW, Christensom ER, Brainherd EE, Flaggs G, Bentley NJ, Taylor EM, Meyn MS, Moss SB et al.: The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev 1996, 10:2423-2437.
5. 1 progression in yeast. Mol Biol Cell 1996, 7:25-42. Demonstrates that the TOR signalling pathway is dedicated to translational control. The cell cycle arrest caused by loss of TOR is a secondary effect of a translational arrest. The authors focus attention on eukaryotic translation initiation factor 4E (elF4E), in addition to ribosomal protein S6, as a target of TOR signalling.
6. Di Como CJ, Amdt KT: Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev 1996, 10:1904-1916. The first identification of downstream effectors of TOR that control translation initiation in yeast. Also demonstrates that TOR responds throughout the cell cycle to changes in carbon source.
7. Hartwell L: cAMPing out. Nature 1994, 371:286.
8. Lin T-A, Kong S, Saltiel AR, Blackshear PJ, Lawrence JC: Control of PHAS-I by insulin in 3T3-L1 adipocytes: synthesis, degradation, and phosphorylation by a rapamycin sensitive and mitogen-activated kinase-independent pathway. J Biol Chem 1995, 270:18531-18538.
9. Beretta L, Gingras A-C, Svitkin YV, Hall MN, Sonenberg N: Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 1996, 15:658-664. Shows that 4E-BP1 and cap-dependent translation are controlled by the TOR pathway.
10. Brown EJ, Schreiber SL: A signaling pathway to translational control. Cell 1996, 86:517-520.
11. s6k.
12. Brunn GJ, Hudson CC, Sekulic A, Williams JM, Hosoi H, Houghton PJ, Lawrence JC Jr, Abraham RT: Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 1997, 277:99-101. Demonstrates for the first time that mTOR can directly phosphorylate 4E-BP1 in vitro and disrupt its ability to interact with eukaryotic translation initiation factor 4E (elF4E). This is also the first demonstration that mTOR is an authentic protein kinase.
13. Altmann M, Schmitz N, Berset C, Trachsel H: A novel inhibitor of cap-dependent translation initiation in yeast: p20 competes with elF4G for binding to elF4E. EMBO J 1997, 16:1114-1121.
14. De La Cruz J, Iost I, Kressler D, Linder P: The p20 and Ded1 proteins have antagonistic roles in elF4E-dependent translation in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1997, 94:5201-5206.
15. Schmidt A, Kunz J, Hall MN: TOR2 is required for organization of the actin cytoskeleton. Proc Natl Acad Sci USA 1996, 93:13780-13785.
16. Schmidt A, Bickle M, Beck T, Hall MN: The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell 1997, 88:531-542. Describes the first identification of downstream effectors in the TOR2 signalling pathway that controls the organization of the actin cytoskeleton.
17. Zheng X-F, Fiorentine D, Chen J, Crabtree GR, Schreiber SL: TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 1995, 62:121-130.
18. Vanhaesebroeck B, Stein RC, Waterfield MD: The study of phosphoinositide 3-kinase function. Cancer Surv: Cell Signalling 1996, 27:249-270.
19. Toker A, Cantley LC: Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 1997, 387:673-673.
20. Mendez R, Myers MG Jr, While MF, Rhoads RE: Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol Cell Biol 1996, 16:2857-2864.
21. Von Manteuffel SR, Gingras A-C, Ming XF, Sonenberg N, Thomas G: 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. Proc Natl Acad Sci USA 1996, 93:4076-4080.
22. Leevers SJ, Weinkove D, MacDougall LK, Hafen E, Waterfield MD: The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J 1996, 15:6584-6594. Underscores the importance of phosphatidylinositol (Pl) 3-kinase in controlling cell growth. Alterations in expression of Pl 3-kinase cause alterations in cell size but not in cell fate.
23. Burgering BM, Coffer PJ: Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995, 376:599-602.
24. Downward J: A target for Pl(3) kinase. Nature 1995, 376:553-554.
25. 389 are differentially regulated by rapamycin-insensitive kinase-kinases. Mol Cell Biol 1996, 16:6242-6251.
26. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
27. Clemens MJ: Protein kinases that phosphorylate elF2 and elF2B, and their role in eukaryotic cell translational control. In Translational Control. Edited by Herehey JW, Mathews MB, Sonenberg N. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1996:139-172.
28. Franke TF, Kaplan D, Cantley LC: P13K: downstream AKTion blocks apoptosis. Cell 1997, 88:435-437.
29. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME: Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 275:661-665.
30. Kauffman-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J. Evan G: Suppression of c-myc-induced apoptosis by Ras signalling through Pl(3)K and PKB. Nature 1997, 385:544-548.
31. Cohen P, Alessi DR, Cross DAE: PDK1, one of the missing links in insulin signal transduction? FEBS Lett 1997, 410:3-10.
32. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PRJ, Reese CB, Cohen P: Characterization of a 3-phospholnositide-dependent protein which phosphorylates and activates protein kinase B. Curr Biol 1997, 7:261-269. Presents the discovery of the 3 phosphoinositide dependent kinase PDK1 PDK1 promises to be a direct effector of Pl 3-kinase.
33. 3 interacts with both PKB and a kinase upstream of PKB, and that both interactions are required for PKB activation.
34. ••].
35. Sonenberg N: mRNA 5′cap-binding protein elF4E and control of cell growth. In Translational Control. Edited by Hershey JW, Mathews MB, Sonenberg N. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1996:245-270.
36. Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM, Vogt PK: Transformation of chicken cells by the gene encoding the catalytic subunit of Pl 3-kinase. Science 1997, 275:1848-1850. Describes the discovery of a retroviral oncogene encoding phosphatidylinositol (Pl) 3-kinase. Underscores the importance of Pl 3-kinase as a regulator of cell growth and proliferation.
37. Rodriguez-Viciana P, Warne PH, Khwaga A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J: Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 1997, 89:457-467.
38. Bellacosa A, Testa JR, Staal SP, Tsichlis PN: A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991, 254:274-277.
39. s6k. FEBS Lett 1997, 410:78-82.
40. ras. Nature 1994, 371:426429.
41. s6k blocks phosphorylation of the same sites in 4E-BP1 that are blocked by rapamycin pretreatment.
42. Fadden P, Haystead TAJ, Lawrence JC: Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes. J Biol Chem 1907, 272:10240-10247.
43. s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J 1995, 21:5279-5287.
44. Meyuhas O, Avni D, Shama S: Translational control of ribosomal protein mRNAs in eukaryotes. In Translational Control. Edited by Hershey JW, Mathews MB, Sonenberg N. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1996:363-388.
45. Rau M, Ohlmann T, Morley SJ, Pain VM: A reevaluation of the cap-binding protein elF4E, as a rate-limiting factor for initiation of translation in reticulocyte lysate. J Biol Chem 1996, 271:8983-8990.
46. Redpath NT, Foulstone EJ, Proud CG: Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J 1996, 15:2291-2297.
47. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR, Roberts JM: Interleukin-2-mediated elimination of the p27 Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994, 372:570-573.
48. Kip1. Mol Cell Biol 1996, 16:6744-6751.
49. Nasmyth K: Retinoblastoma protein. Another role rolls in. Nature 1996, 382:28-29.